These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18946055)

  • 21. Design and synthesis of potent inhibitors of cholesteryl ester transfer protein (CETP) exploiting a 1,2,3,4-tetrahydroquinoline platform.
    Rano TA; Sieber-McMaster E; Pelton PD; Yang M; Demarest KT; Kuo GH
    Bioorg Med Chem Lett; 2009 May; 19(9):2456-60. PubMed ID: 19339179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LOX-1 and atherosclerosis: proof of concept in LOX-1-knockout mice.
    Morawietz H
    Circ Res; 2007 Jun; 100(11):1534-6. PubMed ID: 17556664
    [No Abstract]   [Full Text] [Related]  

  • 23. Cholesteryl ester transfer protein I405V polymorphism influences apolipoprotein A-I response to a change in dietary fatty acid composition.
    Darabi M; Abolfathi AA; Noori M; Kazemi A; Ostadrahimi A; Rahimipour A; Darabi M; Ghatrehsamani K
    Horm Metab Res; 2009 Jul; 41(7):554-8. PubMed ID: 19242900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidant supplements and simvastatin-niacin therapy.
    Netke S; Ivanov V; Roomi W; Niedzwiecki A; Rath M
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2099-100. PubMed ID: 11742891
    [No Abstract]   [Full Text] [Related]  

  • 25. Apolipoprotein A-I mimetic peptides.
    Hovingh GK; Bochem AE; Kastelein JJ
    Curr Opin Lipidol; 2010 Dec; 21(6):481-6. PubMed ID: 21042216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARgamma1-induced caveolin-1 enhances cholesterol efflux and attenuates atherosclerosis in apolipoprotein E-deficient mice.
    Hu Q; Zhang XJ; Liu CX; Wang XP; Zhang Y
    J Vasc Res; 2010; 47(1):69-79. PubMed ID: 19729954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of apolipoprotein e polymorphism on plasma cholesteryl ester transfer protein activity in type 2 diabetic patients].
    Chaaba R; Attia N; Hammami S; Smaoui M; Ben Hamda K; Mahjob S; Hammami M
    Mol Biol (Mosk); 2008; 42(6):931-6. PubMed ID: 19140312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human paraoxonase gene cluster transgenic overexpression represses atherogenesis and promotes atherosclerotic plaque stability in ApoE-null mice.
    She ZG; Zheng W; Wei YS; Chen HZ; Wang AB; Li HL; Liu G; Zhang R; Liu JJ; Stallcup WB; Zhou Z; Liu DP; Liang CC
    Circ Res; 2009 May; 104(10):1160-8. PubMed ID: 19359600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique pathway for cholesterol uptake in fat cells.
    Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1538-9. PubMed ID: 15345518
    [No Abstract]   [Full Text] [Related]  

  • 30. Is LPL deficiency atherogenic?
    Ebara T; Murase T; Okubo M
    Circ Res; 2008 Jun; 102(11):e118; author reply e119. PubMed ID: 18535262
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g).
    Alrasadi K; Awan Z; Alwaili K; Ruel I; Hafiane A; Krimbou L; Genest J
    Am J Cardiol; 2008 Nov; 102(10):1341-7. PubMed ID: 18993152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences in systemic inflammation and atheroma formation following Porphyromonas gingivalis infection in heterozygous apolipoprotein E-deficient mice.
    Champagne C; Yoshinari N; Oetjen JA; Riché EL; Beck JD; Offenbacher S
    J Periodontal Res; 2009 Oct; 44(5):569-77. PubMed ID: 18973527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein-AI-containing particles and atherosclerosis.
    Fruchart JC; Castro G; Duriez P
    Isr J Med Sci; 1996 Jun; 32(6):498-502. PubMed ID: 8682658
    [No Abstract]   [Full Text] [Related]  

  • 34. Generation of adipose tissue-specific transgenic mouse models.
    Jiang XC
    Methods Mol Biol; 2008; 456():55-64. PubMed ID: 18516552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological therapies for raising HDL cholesterol beyond synthetic small molecules.
    Garcia RA
    Curr Opin Investig Drugs; 2008 Mar; 9(3):274-80. PubMed ID: 18311663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetics and molecular biology.
    Talmud PJ; Waterworth DM
    Curr Opin Lipidol; 1999 Apr; 10(2):181-3. PubMed ID: 10327287
    [No Abstract]   [Full Text] [Related]  

  • 37. Fixed-dose combination of extended-release niacin plus simvastatin for lipid disorders.
    Vo AN; Kashyap ML
    Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1303-10. PubMed ID: 19018682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anthocyanins from purple sweet potato Ipomoea batatas cultivar Ayamurasaki suppress the development of atherosclerotic lesions and both enhancements of oxidative stress and soluble vascular cell adhesion molecule-1 in apolipoprotein E-deficient mice.
    Miyazaki K; Makino K; Iwadate E; Deguchi Y; Ishikawa F
    J Agric Food Chem; 2008 Dec; 56(23):11485-92. PubMed ID: 18986148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atheroprotective and plaque-stabilizing effects of enzymatically modified isoquercitrin in atherogenic apoE-deficient mice.
    Motoyama K; Koyama H; Moriwaki M; Emura K; Okuyama S; Sato E; Inoue M; Shioi A; Nishizawa Y
    Nutrition; 2009 Apr; 25(4):421-7. PubMed ID: 19026522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.